Published in Gene Therapy Weekly, September 19th, 2002
The study was published in the prestigious Journal of Clinical Investigation.
TNFerade, GenVec's lead oncology product candidate, is in phase IIb clinical trials in patients with pancreatic cancer. TNFerade is being tested in combination with standard radiation therapy and the chemotherapeutic drug, fluorouracil,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.